360Quadrants Publishes Best E-Commerce Platforms in 2020

 E-commerce platform allows organizations to offer goods and services digitally. This platform handles back-end processes such as billing, order processing, product control, and customer support. With an integrated e-commerce platform, all these functions can be handled from a unified interface, and switching between the apps gets eliminated. This, in return, enhance employee productivity and allows organizations to serve customers better. 

 

360Quadrants, the most granular comparison platform, has released a quadrant on Best E-Commerce Platforms to help businesses make quicker and more informed decisions. Quadrants are generated post analysis of companies (product portfolios and business strategy) and will be updated every three months based on market and regional analyses and developments in E-Commerce Platforms space. 360Quadrants conducts an in-depth SWOT analysis and accurately analyses the companies considered for evaluation. This helps service providers in learning about new opportunities and areas where they lag behind their peers. It also helps clients in choosing the most appropriate vendor for their specific requirements. 

 

Read More: - https://www.360quadrants.com/press-release/360quadrants-releases-quadrant-on-best-e-commerce-platforms

 

E-commerce Platforms Competitive Landscape 

360Quadrants evaluated over 40 companies in the E-Commerce Platforms space, out of which, 19 companies are categorized as Visionary Leaders, Innovators, Dynamic Differentiators, and Emerging Companies. 

 

Shopify, WooCommerce, BigCommerce, and Ecwid have been recognized as visionary leaders as they have established product offerings, and they focus on further strengthening their market position. 

 

Shopmatic, Zepo, Zoey, Ecomchain, and Storm have been considered as innovators. These companies focus on product innovations and invest heavily in R&D to expand their product portfolios.  

 

Digital River, Handshake, Kartrocket, and Teespring have been listed as emerging companies. These players provide a unique range of products but have a limited market approach. 

2Checkout, Paypro Global, Square E-Commerce, nopCommerce, Sellfy, and Prestashop have been identified as dynamic differentiators. These companies rely mostly on their innovative research and development infrastructure. 

 

Report explores the Hollow Fiber Filtration Market worth $517.4 million by 2023

The growth of this market can be attributed to the rising preference for continuous manufacturing in the biopharmaceutical industry and the increasing demand for biopharmaceuticals across the globe.

The Hollow Fiber Filtration Market is projected to reach USD 517.4 million by 2023 from USD 274.7 million in 2018, growing at a CAGR of 13.5%. 

Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267011039

On the basis of application, the hollow fiber filtration market is segmented into continuous cell perfusion, harvest and clarification, and concentration and diafiltration. In 2018, continuous cell perfusion is expected to be the largest application segment in the hollow fiber filtration market. The biopharmaceutical industry is actively exploring the potential of continuous manufacturing, with a focus on upstream perfusion cell-culture processes that utilize hollow fiber filters. 

On the basis of material, the hollow fiber filtration market is segmented into polymeric and ceramic materials. In 2018, the polymeric hollow fiber filtration segment is expected to account for a larger share of the market as these filters are widely used in several ultrafiltration and microfiltration applications, including filtration, desalination, and biochemical reactions.

The Asian Pacific is expected to be the fastest-growing regional market for hollow fiber filtration. The high growth in this regional market can be attributed to the expansion of the biomanufacturing sector, increasing government support, developing R&D infrastructure, and growing outsourcing of bioproduction processes to Asia Pacific countries such as China and India.

Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=267011039  

The hollow fiber filtration market is consolidated due to the presence of a few major players. Asahi Kasei Corporation (Japan), Repligen Corporation (US), GE Healthcare (US), Danaher Corporation (US), and Koch Membrane Systems (US) are the leading players in this market.

Technology Advancement in Surgical Robots Market

The technological advancements in surgical robots, the increasing adoption of surgical robots, the various advantages of robotic-assisted surgery, and the increase in funding for medical robot research are the key drivers of the surgical robots market. Increasing penetration of surgical robots in ASCs and emerging markets are also supporting the growth of this market.

The report Surgical Robots Market  is expected to reach USD 11.8 billion by 2025 from USD 6.7 billion in 2020, at a CAGR of 12.1%.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256618532

The surgical robots market is segmented based on product & service into robotic systems, instruments & accessories, and services. The instruments & accessories segment is expected to command the largest share of the market in 2020 and is estimated to grow at the highest CAGR during the forecast period. The recurrent purchase of instruments & accessories as opposed to robotic systems, which are a one-time investment, is the major factor driving the growth of this product segment.

The market is segmented into general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and other applications based on applications. The general surgery applications segment is estimated to command the largest share of the market in 2020, and this segment is also projected to register the highest CAGR owing to increased use of surgical robots in general procedures such as bariatric surgery, Heller myotomy, gastrectomy, hernia repair, cholecystectomy, transoral surgery, and pancreatectomy.

While North America is expected to dominate the global surgical robots market in 2020, the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to the increasing demand from key markets such as Japan and China and the large patient population in India. Due to this, the availability of robots has also grown in this region.

Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=256618532

The major players operating in the surgical robots market include Intuitive Surgical (US), Stryker (US), and Medtronic (Ireland). The other players in this market include Smith & Nephew (UK), Zimmer Biomet (US), Renishaw (UK), Auris Health (US), Medrobotics (US), TransEnterix (US), THINK Surgical (US), CMR Surgical (UK), Corindus Vascular Robotics (US), Verb Surgical (US), OMNIlife science Inc. (US), Preceyes BV (Netherlands), Microsure (Netherlands), Titan Medical Inc. (Canada), AvateraMedical GmbH (Germany), Medicaroid Corporation (Japan), TINAVI Medical Technology Co. Ltd. (China), AOT AG (Switzerland), Robocath (France), Rob Surgical Systems (Spain), Siasun Robot & Automation Co. Ltd. (China), and Meere Company (Korea).

 

360quadrants Releases Quadrant on Best E-Commerce Platforms

E-commerce platforms are a tech framework that help company owners control their selling activities digitally. Several market vendors provide various platforms of ecommerce to match various business needs. Each platform has its own benefits and drawbacks, and companies choose the one that fits their needs. E-commerce platforms typically represent the front end aspect of a company and facilitates online selling of goods to the customers. 

 360Quadrants, the most granular comparison platform, has released a quadrant on Best E-Commerce Platforms to help businesses make quicker and more informed decisions. Quadrants are generated post analysis of companies (product portfolios and business strategies) and will be updated every three months based on market and regional analyses and developments in the E-Commerce Platforms space. 360Quadrants conducts an in-depth SWOT analysis and accurately analyzes the companies considered for evaluation. This helps service providers in learning about new opportunities and areas where they lag behind their peers. It also helps clients in choosing the most appropriate vendor for their requirements. 

 

Know More: - https://www.360quadrants.com/press-release/360quadrants-releases-quadrant-on-best-e-commerce-platforms

 

Categorization of E-commerce Platform Providers 

 

360Quadrants evaluated over 35 companies in the E-Commerce Platforms space out of which 19 companies were categorized as Visionary Leaders, Innovators, Dynamic Differentiators, and Emerging Companies. 

 

Shopify, WooCommerce, BigCommerce, and Ecwid have been identified as visionary leaders as they have established product portfolios and a robust market presence and business strategies. 

Shopmatic, Zepo, Zoey, Ecomchain, and Storm have been identified as innovators as they have focused product portfolios, and innovative business strategies which help them in growing consistently.  

 

Digital River, Handshake, Kartrocket, and Teespring have been identified as emerging companies as they have niche product offerings and decent business strategies. 

2Checkout, Paypro Global, Square E-Commerce, nopCommerce, Sellfy, and Prestashop have been recognized as dynamic differentiators as they are largely dependent on their competitive R&D activities. 

 

Clinical Workflow Solutions Market: Emerging Trends and Global Future Forecast

 The major factors driving the growth of this market are the rising need to curtail healthcare costs and the increasing patient volume due to the rising prevalence of chronic diseases. In addition, the government initiatives for HCIT adoption and the advantages of clinical workflow solutions in enhancing patient care and safety are also boosting the market growth.

The Clinical Workflow Solutions Market is projected to reach USD 18.1 billion by 2025 from USD 9.1 billion in 2020, at a CAGR of 14.8% during the forecast period.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=146901412  

Based on products, the clinical workflow solutions market is segmented into workflow automation solutions, care collaboration solutions, real-time communication solutions, data integration solutions, and enterprise reporting and analytics solutions. The data integration segment is estimated to account for the largest market share in 2019. The large share of this segment can be attributed to the growing requirement for a proper management and storage solution that can manage the increasing volume of medical records. Also the government incentives, penalties, and the necessity to cut costs are contributing towards the market growth.

Based on end users, the clinical workflow solutions market is segmented into hospitals, long-term care facilities, and ambulatory care facilities. The hospital segment is estimated to account for the largest market share in 2019. This is because increasing number of initiatives to improve the quality of care delivered to patients and the growing need to improve profitability of healthcare operations and curtail healthcare costs. 

North America is expected to account for the largest share of the clinical workflow solutions market in 2019, followed by Europe. The dominance of the North American region can be attributed to the growing healthcare IT spending, developed infrastructure, evolving regulations for better healthcare outcomes, and the presence of major market players in the region. 

Speak To Analyst: -https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=146901412  

The prominent players in the clinical workflow solutions market are are Hill-Rom Holdings, Inc. (US), Ascom Holding AG (Switzerland), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Cisco Systems, Inc. (US), Stanley Black & Decker, Inc. (US), Cerner Corporation (US), Infor, Inc. (US), Allscripts Healthcare Solutions, Inc. (US), and McKesson Corporation (US).

Infusion Pump Software Market to witness major growth in coming years

 Growth in the infusion pump software market is mainly driven by factors such as the increasing incidence of chronic diseases, along with rapid growth in the geriatric population, growing number of surgical procedures performed, rising demand for ambulatory and home care infusion pumps, and technological developments.

The global Infusion Pump Software Market is expected to reach USD 1,044 million by 2024 from USD 742 million in 2019, at a CAGR of 7.1%. 

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=126400367

 On the basis of type, the infusion pump software market is segmented into Dose error reduction software (DERS), clinical workflow software, interoperability software and other software. The DERS segment held the largest share of the infusion pump software market in 2018 and this segment is also projected to register the highest growth during the forecast period. Increasing number of medication errors using infusion pumps is a major factor driving market growth. The various automated safety features offered by this software also supporting the adoption of DERS in infusion pumps.

On the basis of indication, the market is segmented into general infusion, pain & anesthesia management, insulin infusion, chemotherapy, enteral infusion, and others. The general infusion segment commanded the largest share of the market in 2018. However, the insulin infusion market is projected to register the highest CAGR owing to a significant increase in the prevalence of diabetes worldwide and the pump’s ease of use for prolonged insulin infusion.

Geographically, North America is expected to dominate the global infusion pump software market in 2018, while the Asia Pacific region is expected to register the highest CAGR during the forecast period. 

Speak To Analyst: -https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=126400367  

The major players operating in the infusion pump software market include BD (US), B. Braun (Germany), Baxter (US), ICU Medical (US), and Terumo Medical (Japan). Other players involved in this market include Fresenius Kabi (Germany), Moog (US), F. Hoffmann-La Roche (Switzerland), Ypsomed (Switzerland), Medtronic (Ireland), Smiths Medical (US), and Micrel Medical Devices (Greece).

Laboratory Proficiency Testing Market worth $1103 million by 2024 explored in latest Research

 Proficiency testing forms an essential precondition for operational excellence and accreditation in several industries. This is one of the major factors driving the growth of the proficiency testing market, globally. Also, the stringent safety and quality regulations for food and pharmaceutical products and the increasing focus on water testing are the other major factors supporting market growth.

The Laboratory Proficiency Testing Market is projected to reach USD 1,103 million by 2024 from USD 800 million in 2019, at a CAGR of 6.6% during the forecast period.

Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144227949

In the laboratory proficiency testing market, by industry, the cannabis/opioids proficiency testing segment is estimated to grow at the highest CAGR during the forecast period. Growth in this segment is primarily driven by the legalization of medical cannabis, growing number of cannabis testing laboratories, rising awareness about the medical use of cannabis, and the increasing availability of analytical testing instruments and software.

In the laboratory proficiency testing market, by technology, the chromatography segment is expected to grow at the highest CAGR during the forecast period. Chromatography is used to carry out complicated separations like amino acid sequencing or pollutant separations, based on differential partitioning between the mobile and stationary phase. The advantages associated with chromatographic testing, such as the increased safety, reliability, and transparency of the pharmaceutical supply chain by testing the identity, strength, purity, quality, and potency of a drug product, and the growth in the pharmaceutical industry as a whole are the major factors driving the growth of this segment.

The Asia Pacific is considered to be the most attractive regional market for laboratory proficiency testing owing to the large base of manufacturers and research laboratories in the region. 

Speak To Analyst:-https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=144227949

The prominent players operating in the global laboratory proficiency testing market are LGC Limited (UK), Bio-Rad Laboratories (US), Randox Laboratories (UK), Merck (Germany), College of American Pathologists (US), American Proficiency Institute (US), Waters Corporation (US), QACS (Greece), FAPAS (UK), AOAC (US), Phenova Inc. (US), Weqas (Cardiff), Advanced Analytical Solutions, LLC (UK), Bipea (France), Absolute Standards Inc. (US), and NSI Lab Solutions (US).

 

Best e-commerce platforms: An Outlook to the Future Global Opportunities

 The Best e-Commerce platform is a comprehensive software tool that allows merchants to build and manage a digital storefront for their products or services. Because best e-Commerce platforms create a centralized, digital hub for product and customer data, they allow eCommerce businesses to do things like customizing product information, manage web content and layout, allow online transactions to occur, and adjust the platform according to businesses’ online needs.

The global market size of Best E-Commerce Platforms has been estimated at USD 6.5 billion in 2019 and is expected to rise at a compound annual growth rate (CAGR) of 16 per cent between 2020 and 2027. E-commerce tech simplifies complicated procedures and lets firms control their inventory, measure taxes and efficiently handle certain business-related functions. Growing people's embrace of online shopping has contributed to a need for many retailers for e-commerce apps.

Read More: - https://www.360quadrants.com/press-release/360quadrants-releases-quadrant-on-best-e-commerce-platforms

In 2019 the cloud segment had the maximum share of the business. This is due to the growing proliferation of cloud-based technologies through various vertical lines of industry. Cloud-based delivery provides many benefits including flexible computing space, streamlined control, fast performance and redundancy. It is projected that the on-premise market would experience a CAGR of over 6.0 per cent between 2020 and 2027. On-premise installation limits the user's complete control and thus decreases the need for extra security. The delivery process allows the customer complete power over the hardware and the program upgrades.

Best E-Commerce Platforms offers hospitals, clinics, and other wellness institutes potential to simplify their buying decision of hospital devices and other supplies. The shift of manufacturing companies of medical devices to digital sites has given market players potential for advancement.

Asia Pacific is expected to see the fastest development over the projected period. This recent surge is due to measures in their respective nations carried out by the government of countries like China and India to encourage digitalisation. Due to this, there has been significant growth in internet users.

The best E-Commerce Platforms tech industry is highly decentralized and marked by strong global competition, as many market participants perform their business operations across the world. The Best E-Commerce Platforms industry has witnessed numerous strategies of inorganic expansion, such as acquisitions and mergers, alliances, and cooperation that businesses have embraced in the past years.

Microtome Market to Progress at a Healthy CAGR in Coming Years

 Microtomes operate on different technologies, including manual, semi-automated, and fully automated. Manual microtomes segment accounted for the largest market share in 2018. Manual microtomes are cost-effective and are easier to use as compared to automatic and semi-automatic modules. These factors are supporting their adoption in the market, and the trend is anticipated to continue over the forecast period.

The report Microtome Market  is expected to grow from USD 129 million in 2019 to reach USD 177 million by 2024, at a CAGR of 6.5%.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=230495411  

Clinical laboratories and hospital laboratories are the main end-users of microtomes, among others. In 2018, the hospital laboratories segment accounted for the largest market share and was expected to grow at the highest CAGR during the forecast period. The large share of the hospital laboratories segment is attributed to the increasing number of patient visits to hospitals, rising number of in-house clinical diagnostic procedures performed in hospitals, growing awareness regarding early diagnosis, and the availability of reimbursements in developed markets for clinical tests performed in hospitals.

By region, the microtomes market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018, North America accounted for the largest market share, followed by Europe. 

Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=230495411

The prominent players operating in the microtomes market include Thermo Fisher Scientific (US), Danaher Corporation (US), Sakura Finetek (Japan), SLEE Medical GmbH (Germany), MEDITE GmbH (Germany), Histo-Line Laboratories (Italy), Amos Scientific (Australia), RMC Boeckeler (US), Diapath S.p.A. (Italy), and Jinhua YIDI Medical Appliance (China).

Isothermal Nucleic Acid Amplification Technology (INAAT) Market – Emerging Trends and Global Future Forecast

Factors such as the rising prevalence of infectious diseases and the introduction of newer pathogens, the need for prompt diagnosis, the increasing number of blood transfusions and donations, and the cost-benefits of INAAT are the key factors driving the market growth.

The report Isothermal Nucleic Acid Amplification Technology/INAAT Market size is expected to grow from USD 1.9 billion in 2019 to USD 3.3 billion by 2024, at a CAGR of 11.0% during the forecast period. 

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=839

Based on the product, the INAAT market is segmented into assay, kits, and reagents, and systems. Assay, kits, and reagents segment are expected to account for the largest share of the INAAT industry in 2019, owing to the factors such as the increasing number of infectious disease diagnostic tests carried out; the growing prevalence of infectious diseases.

Based on the type, the global market is divided into TMA, LAMP, SDA, HAD, NASBA, and other technologies. The TMA segment is expected to account for the largest share of the global INAAT industry in 2019. The large share of this segment is attributed to the growing reliance on POC diagnosis in hospitals and blood banks.

Based on application, the INAAT market is segmented into infectious disease diagnosis, blood screening, and other applications such as cancer diagnosis, cancer research, and laboratory research, which encompass cDNA preparation, whole-genome amplification (WGA), single-nucleotide polymorphism (SNP), and mutation analysis. 

Based on the end user, the market is divided into hospitals, reference laboratories, academic and research institutes, and other end users. 

In 2019, North America is expected to account for the largest share of the global INAAT market, followed by Europe. 

Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=839

The major companies in the global INAAT market include Grifols S.A. (Spain), Hologic, Inc. (US), Abbott Laboratories, Inc. (US), Becton, Dickinson & Company (US), and Meridian Bioscience (US).

European Medical Devices Market to witness major growth in coming years

Factors such as the rising geriatric population, large and established medical technology industry, increasing number of surgical procedures, growing need for cost-containment in the healthcare industry, and the availability of funding for research and product innovation are driving the growth of this market. However, fiscal unsustainability due to wasteful spending might hamper the market growth to a certain extent. 

The report European Medical Devices Market is projected to reach USD 61.4 billion by 2025 from an estimated USD 48.9 billion in 2020, at a CAGR of 4.7% during the forecast period. 

Download PDF Brochure:-  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=241277169  

Based on device type, the market has been segmented into orthopedic devices, diagnostic imaging systems, endoscopy devices, ophthalmic devices, interventional cardiology devices, cardiac monitoring and cardiac rhythm management devices, respiratory care devices, ventilators, anesthesia monitoring devices, dialysis devices, and diabetic care devices. The orthopedic devices segment accounted for the largest share of the European medical devices market in 2019. The growing incidence of orthopedic disorders such as arthritis, osteoporosis, soft-tissue injuries, and fractures among the elderly population is expected to drive the demand for orthopedic devices in Europe.

Based on end-user, the European medical devices market is segmented into hospitals and clinical care settings and home care settings. Hospitals and clinical care settings were the largest end-users of medical devices in Europe in 2019. This can largely be attributed to the financial capabilities of hospitals to purchase expensive devices as well as the availability of trained professionals in hospitals to operate these devices.

Germany accounted for the largest share of the European medical device market in 2019. The rising geriatric population and the presence of strong healthcare infrastructure in the country are the major factors that are driving the demand for medical devices in Germany.

Speak To Analyst:-https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=241277169

The prominent players in the global European medical device market are Siemens Healthineers (Germany), GE Healthcare (US), Philips (Netherlands), Abbott (US), Medtronic (Ireland), Stryker (US), Boston Scientific (US), Asahi Kasei Medical (Japan), B. Braun (Germany),  Baxter International, Inc. (US), ResMed (US), Masimo (US), and KARL STORZ (Germany).

360Quadrants Publishes Best E-Commerce Platforms in 2020

 E-commerce platform allows organizations to offer goods and services digitally. This platform handles back-end processes such as billing, order processing, product control, and customer support. With an integrated e-commerce platform, all these functions can be handled from a unified interface, and switching between the apps gets eliminated. This, in return, enhance employee productivity and allows organizations to serve customers better. 

 

360Quadrants, the most granular comparison platform, has released a quadrant on Best E-Commerce Platforms to help businesses make quicker and more informed decisions. Quadrants are generated post analysis of companies (product portfolios and business strategy) and will be updated every three months based on market and regional analyses and developments in E-Commerce Platforms space. 360Quadrants conducts an in-depth SWOT analysis and accurately analyses the companies considered for evaluation. This helps service providers in learning about new opportunities and areas where they lag behind their peers. It also helps clients in choosing the most appropriate vendor for their specific requirements. 

 

Read More: - https://www.360quadrants.com/press-release/360quadrants-releases-quadrant-on-best-e-commerce-platforms

 

E-commerce Platforms Competitive Landscape 

360Quadrants evaluated over 40 companies in the E-Commerce Platforms space, out of which, 19 companies are categorized as Visionary Leaders, Innovators, Dynamic Differentiators, and Emerging Companies. 

 

Shopify, WooCommerce, BigCommerce, and Ecwid have been recognized as visionary leaders as they have established product offerings, and they focus on further strengthening their market position. 

 

Shopmatic, Zepo, Zoey, Ecomchain, and Storm have been considered as innovators. These companies focus on product innovations and invest heavily in R&D to expand their product portfolios.  

 

Digital River, Handshake, Kartrocket, and Teespring have been listed as emerging companies. These players provide a unique range of products but have a limited market approach. 

2Checkout, Paypro Global, Square E-Commerce, nopCommerce, Sellfy, and Prestashop have been identified as dynamic differentiators. These companies rely mostly on their innovative research and development infrastructure. 

 

The U.S. to Witness High Growth in the North American Drug Delivery Technologies Market

 Factors such as rising prevalence of chronic diseases, growth in the biologics market, funding initiatives for drug delivery research, and technological advancements are driving the growth of this market.

The North American Drug Delivery Technologies Market is projected to reach USD 758.7 Billion by 2021 from USD 520.0 Billion in 2016, at a CAGR of 6.5%.

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1209            

In this report, the North American drug delivery technologies market is segmented on the basis of route of administration, end user, and region. Based on end user, the market is segmented into hospitals, ambulatory surgical centers (ASCs)/clinics, home care settings, and other end users. The home care settings segment is expected to register the highest CAGR during the forecast period. Improving patient acceptability, patient awareness, and the need for comfortable usability have increased the use of drug delivery systems in home care settings, thus contributing to the growth of this end-user segment.

Based on route of administration, the North American drug delivery technologies market is segmented into oral, pulmonary, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery. The topical drug delivery market is expected to grow at the highest CAGR during the forecast period. 

The North American drug delivery technologies market is divided into two country-level segments, namely, the U.S. and Canada. The U.S. is expected to continue to dominate the market during the forecast period. 

Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=1209

Johnson & Johnson, Inc. (U.S.), Novartis AG (Switzerland), F. Hoffman-La-Roche Ltd. (Switzerland), Bayer AG (Germany), Pfizer, Inc. (U.S.), 3M Company (U.S.), Becton, Dickinson and Company (U.S.), Merck & Co, Inc. (U.S.), Sanofi (France), Antares Pharma, Inc. (U.S.), and GlaxoSmithKline Plc. (U.K.) are some of the prominent players in the North American drug delivery technologies market.

 

Cardiac Marker Testing Market: Emerging Trends and Global Future Forecast

The report Cardiac Marker Testing Market analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

This report studies the global Cardiac Marker Testing Market over the forecast period of 2016 to 2021. The market is expected to reach ~USD 3.50 Billion by 2021, at a CAGR of 8.8% from 2016 to 2021. 

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64885447  

A number of factors such as growing incidences of cardiovascular diseases, the rapidly increasing geriatric population, growing funding from public–private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are fueling the growth of the cardiac marker testing market.

Based on type, the global cardiac marker testing market is divided into six segments, namely, troponin I and T, CK-MB, BNP or NT-proBNP, Myoglobin, hsCRP, and other biomarkers. The other biomarkers segment includes galectin-3, H-FABP, myeloperoxidase, ischemia-modified albumin, and homocysteine.

On the basis of product, the global cardiac marker testing market is segmented into reagents and kits and instruments. The instruments section is further segmented on the basis of method, namely, chemiluminescence, immunofluorescence, ELISA, and immunochromatography. On the basis of disease, the cardiac marker testing market is segmented into myocardial infarction and congestive heart failure. On the basis of type of testing, the cardiac marker testing market is segmented into laboratory testing and point-of-care testing.

As of 2016, North America held the largest share of the global cardiac marker testing market, followed by Europe. However, the Asia-Pacific market is expected to register the highest CAGR of 11.7% from 2016 to 2021. 

Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=64885447  

Roche Diagnostics Ltd. (Switzerland), Abbott Laboratories (U.S.), Siemens AG (Germany), Danaher Corporation (U.S.) Alere, Inc. (U.S.), bioMérieux SA (France), LSI Medience Corporation (a subsidiary of Mitsubishi Chemical Holdings Corporation, Japan), Ortho Clinical Diagnostics (a subsidiary of The Carlyle Group, U.S.), Randox laboratories Ltd (U.K.), and Guangzhou Wondfo Biotech Co., Ltd. (Wondfo) (China) are some of the key players operating in the global cardiac marker testing market.

Cell Analysis Market to witness major growth in coming years

 Factors such as the presence of a favorable business environment, growing government support through funds and grants, growing number of research activities, rising number of drug discovery initiatives by pharmaceutical & biotechnology companies in the US, and the strong presence of key players in this region are driving the growth of the cell analysis market in North America.

The Cell Analysis Market is expected to reach USD 22.7 billion by 2024 from USD 16.0 billion in 2019, at a CAGR of 7.2%. from 2019 to 2024. Increasing government funding for cell-based research and the rising incidence of chronic and infectious diseases are the major factors driving the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157543946

Based on product, the cell analysis market is broadly categorized into microscopes, flow cytometry products, spectrophotometers, qPCR products, cell counters, cell microarrays, high-content screening (HCS) systems, and other products. The flow cytometry products segment accounted for the largest market share in 2018. The large share of this segment is primarily attributed to technological advancements, the increasing adoption of flow cytometry techniques in research and academia, growing public-private initiatives in the field of immunology and immuno-oncology research, and the rising incidence and prevalence of chronic diseases.

Based on end user, the cell analysis market is segmented into hospitals & diagnostic laboratories, research institutes, pharmaceutical & biotechnology companies and CROs, cell culture collection repositories, and other end users. The pharmaceutical & biotechnology companies and CROs segment is expected to register the highest CAGR during the forecast period. These facilities use cell analysis instruments and consumables during various stages of drug discovery, drug research and development, pharmacokinetics, toxicology, and clinical studies.

By region, the cell analysis market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest market share, followed by Europe.

Speak To Analyst: -https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=157543946

The prominent players operating in the cell analysis market are Danaher Corporation (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck KGaA (Germany), GE Healthcare (US), Agilent Technologies, Inc. (US), Olympus Corporation (Japan), PerkinElmer, Inc. (US), Promega Corporation (US), Tecan Group (Switzerland), Miltenyi Biotec (Germany), Carl Zeiss (Germany), Bio-Rad Laboratories Inc (US), and Sysmex Corporation (Japan).

Technology Advancement in Best E-Commerce Platforms

 High spending capacity combined with an increase in spending on apparel is expected to upsurge the growth of the global eCommerce platform market over the next few years. Furthermore, the eCommerce industry has grown unusually well in the earlier years and is expected to witness exponential growth in the upcoming years.

The E-commerce platforms help businesses in handling the online store processes, right from their inventory, to adding or eliminating products, to calculating taxes and fulfilling orders in the best possible way. The Best e-commerce platforms market has an estimated value of around 5.6 billion U.S. dollars in 2020 and is estimated to grow to approximately 6.7 billion U.S. dollars by 2023. With the fast growth of e-commerce sales, international retail e-commerce sales are predicted to reach 6.6 trillion U.S. dollars by 2023.

Know More: - https://www.360quadrants.com/press-release/360quadrants-releases-quadrant-on-best-e-commerce-platforms

 

Market Segmentation

The market is categorized in five major regions that include North America, Asia Pacific, Europe, Middle East & Africa and Latin America regions. Amongst these regions, Asia Pacific is likely to lead the overall ecommerce platform market over the next few years. Increasing number of business formations is providing the best opportunities for the e-commerce platform service providers.

Based on type of platform, the market is classified into, commerce, order management, business intelligence, shipping and others, amongst which, commerce is accounted for the biggest market share in complete worldwide ecommerce platform market.

Technology Overview

best e-Commerce platforms also be termed as a shopping cart solution, shopping cart software, ecommerce website builder, online store builder or ecommerce platform and it caters a sole purpose that is to help businesses in selling their products online. Ecommerce platform comprises customizable site templates, a unified shopping cart, SEO, email marketing, inventory management and analytics.

 E-Commerce Platform: Drivers and Limitations

The international e-Commerce platform market is driven by the software that is user-friendly and also inexpensive for small scale businesses. The price of adding an ecommerce constituent to present business and enter in a newer market falls anywhere between US$ 100 to US$ 150 per month and it allows expansion through online business. 

e-commerce is quickly accounting for a larger quantity of the total retail sales in the U.S. According to the U.S. Department of Commerce, customers spent about US$ 194 billion online in 2011. With this kind of consumption and trend, a growing number of small and mid-size companies are taking the online platform for all or some of its operations.

However, higher prices of hybrid and cloud based software and low internet penetration rate in emergent countries are some of the important factors which are likely to restrict the growth of global ecommerce market in the near future. 

Animal Growth Promoters Market – Emerging Trends and Global Future Forecast to 2024

 The growth of this market is primarily driven by the increasing global meat demand, research into alternatives to antibiotics, and the need to deal with epidemics and environmental factors. However, various countries have stringent regulations in place against antibiotics and particular growth promoters, which has affected their adoption.

The report Animal Growth Promoters and Performance Enhancers Market is projected to reach USD 18.5 billion by 2024 from an estimated USD 13.9 billion in 2019, at a CAGR of 5.9% during the forecast period.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137134167

Based on type, the animal growth promoters and performance enhancers market is segmented into antibiotic and non-antibiotic growth promoters. The non-antibiotic growth promoters segment accounted for the largest share of the animal growth promoters and performance enhancers market in 2018. The large share of this segment can be attributed to their economic benefits, the wide range of substances with applications in different production animals, environmental sustainability, and the increasing number of regulations on antibiotics and hormones.

On the basis of animal type, the animal growth promoters and performance enhancers market is segmented into poultry, swine, livestock, aquaculture, and other farm animals (equine, rabbit, camel, deer, yak, and geese). In 2019, the poultry segment accounted for the largest share of the animal growth promoters and performance enhancers market. 

In 2019, the Asia Pacific region accounted for the largest market share of 36.7%, followed by North America (26.1%) in 2018. The largest share of the Asia Pacific region is attributed to the strong animal products industry in this region, 

Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=137134167  

The key players in the global animal growth promoters and performance enhancers market are Merck and Co. Inc. (US), Cargill Inc. (US), Royal DSM N.V. (Germany), Vetoquinol (France), Bupo Animal Health (SA), Elanco Animal Health Inc. (US), CHR Hansen (UK), Novus International Inc. (US),  BASF SE (UK), Lallemond Inc. (Canada), Bluestar Adisseo Company (France), Evonik Industries AG (UK), and Land O Lake Inc.(US).